All articles by Juliet Martin

Juliet Martin

War in Ukraine: What it means for clinical trial operations

Free Webinar Clinical trials in Ukraine – a first hand perspective Damage to infrastructure, supply chain disruption, patient and researcher…

How to navigate changes in the global clinical trial map

Free Webinar Clinical trials in Ukraine – a first hand perspective Damage to infrastructure, supply chain disruption, patient and researcher…

New territories: Challenges and benefits for western biotechs in China

According to a new report by GlobalData in partnership with leading biotech contract research organisation (CRO) Novotech, the current state of play in China’s pharmaceutical market is offering unique advantages for western biopharma companies looking to expand.

The next generation of DCTs: inside the technology transforming clinical trials

Free Whitepaper The China Biotech Landscape – Opportunities in China and the Path to USFDA Approval For global biopharma companies…

How Pre-Production Services remove downstream obstacles

Free Whitepaper Manufacturing trends: pushing point-of care testing to the molecular level Point-of-care testing (POCT) is widely used for monitoring…

A booming market: Why the Chinese biotech sector is primed for growth

Free Whitepaper The China Biotech Landscape – Opportunities in China and the Path to USFDA Approval For global biopharma companies…

The effect of post-Brexit status on clinical trial logistics

Free Whitepaper Five strategies to optimise clinical trial customs tax in Europe The VAT and customs implications of clinical trials…

Clinical trial trends in 2022: Prepare for an agile future

Free Whitepaper The China Biotech Landscape – Opportunities in China and the Path to USFDA Approval For global biopharma companies…

Why Asia-Pacific is the next frontier for decentralised clinical trials

Rapid growth in the Asia-Pacific (APAC) clinical research market has created strong opportunities for conducting decentralized clinical trials in the region. APAC has become an industry hub and is the fastest growing region for clinical trials globally.